SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 82 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,463,000 | +34.8% | 120,981 | -7.4% | 0.11% | +32.1% |
| Q4 2014 | $1,085,000 | -3.6% | 130,711 | +1.0% | 0.08% | -1.2% |
| Q3 2014 | $1,125,000 | -32.9% | 129,411 | -15.4% | 0.08% | -31.7% |
| Q2 2014 | $1,676,000 | +23.3% | 153,031 | +0.7% | 0.12% | +17.6% |
| Q1 2014 | $1,359,000 | +14.2% | 152,031 | -3.7% | 0.10% | +7.4% |
| Q4 2013 | $1,190,000 | +9.0% | 157,820 | +6.0% | 0.10% | +3.3% |
| Q3 2013 | $1,092,000 | – | 148,920 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |